75 related articles for article (PubMed ID: 12643740)
21. Synthesis of Dextran-Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity.
Yee EMH; Cirillo G; Brandl MB; Black DS; Vittorio O; Kumar N
Front Bioeng Biotechnol; 2019; 7():183. PubMed ID: 31440502
[TBL] [Abstract][Full Text] [Related]
22. Antibody drug conjugate, a level-up version of monoclonal antibody?
Yang Y; Zheng Y; Sun X; Zhao A; Wu Y
Int J Surg; 2024 Jun; ():. PubMed ID: 38833359
[No Abstract] [Full Text] [Related]
23. The antibody-drug conjugate landscape.
Flynn P; Suryaprakash S; Grossman D; Panier V; Wu J
Nat Rev Drug Discov; 2024 Apr; ():. PubMed ID: 38627573
[No Abstract] [Full Text] [Related]
24. 3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery.
Hao W; Zheng Z; Zhu L; Pang L; Ma J; Zhu S; Du L; Jin Y
Asian J Pharm Sci; 2021 Jan; 16(1):86-96. PubMed ID: 33613732
[TBL] [Abstract][Full Text] [Related]
25. MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates.
Abedi M; Ahangari Cohan R; Mahboudi F; Shafiee Ardestani M; Davami F
Iran Biomed J; 2019 Nov; 23(6):395-403. PubMed ID: 31104399
[TBL] [Abstract][Full Text] [Related]
26. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
[TBL] [Abstract][Full Text] [Related]
27. Prodrug Strategies for Paclitaxel.
Meng Z; Lv Q; Lu J; Yao H; Lv X; Jiang F; Lu A; Zhang G
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223283
[TBL] [Abstract][Full Text] [Related]
28. Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy.
Yang Y; Guo Q; Chen X; Zhang J; Guo H; Qian W; Hou S; Dai J; Li B; Guo Y; Wang H
MAbs; 2016; 8(2):405-13. PubMed ID: 26760045
[TBL] [Abstract][Full Text] [Related]
29. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
Singh SK; Luisi DL; Pak RH
Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
[TBL] [Abstract][Full Text] [Related]
30. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
[TBL] [Abstract][Full Text] [Related]
31. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
McCombs JR; Owen SC
AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
[TBL] [Abstract][Full Text] [Related]
32. Preparation of anti-HER2 monoclonal antibody-paclitaxel immunoconjugate and its biological evaluation.
Liu D; Xu Y; Rao Z; Chen Z
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):735-740. PubMed ID: 22173491
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.
Li S; Gray BP; McGuire MJ; Brown KC
Bioorg Med Chem; 2011 Sep; 19(18):5480-9. PubMed ID: 21868241
[TBL] [Abstract][Full Text] [Related]
34. Analytical methods for physicochemical characterization of antibody drug conjugates.
Wakankar A; Chen Y; Gokarn Y; Jacobson FS
MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
[TBL] [Abstract][Full Text] [Related]
35. Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.
Ming X; Alam MR; Fisher M; Yan Y; Chen X; Juliano RL
Nucleic Acids Res; 2010 Oct; 38(19):6567-76. PubMed ID: 20551131
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.
Quiles S; Raisch KP; Sanford LL; Bonner JA; Safavy A
J Med Chem; 2010 Jan; 53(2):586-94. PubMed ID: 19958000
[TBL] [Abstract][Full Text] [Related]
37. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents.
Nakagawa-Goto K; Yamada K; Nakamura S; Chen TH; Chiang PC; Bastow KF; Wang SC; Spohn B; Hung MC; Lee FY; Lee FC; Lee KH
Bioorg Med Chem Lett; 2007 Sep; 17(18):5204-9. PubMed ID: 17643301
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
39. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
